Works matching AU Lacy, Martha
Results: 235
Current status of stem cell transplantation for multiple myeloma.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01039-1
- By:
- Publication type:
- Article
Mode of progression in smoldering multiple myeloma: a study of 406 patients.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00980-5
- By:
- Publication type:
- Article
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00957-w
- By:
- Publication type:
- Article
Muscle and fat composition in patients with newly diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00934-3
- By:
- Publication type:
- Article
Long-term outcomes of allogeneic stem cell transplant in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00900-z
- By:
- Publication type:
- Article
Conditional survival in multiple myeloma and impact of prognostic factors over time.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00852-4
- By:
- Publication type:
- Article
Conditional survival in multiple myeloma and impact of prognostic factors over time.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00852-4
- By:
- Publication type:
- Article
Defining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00785-y
- By:
- Publication type:
- Article
Second- and third-line treatment strategies in multiple myeloma: a referral-center experience.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 12, p. 1, doi. 10.1038/s41408-022-00757-8
- By:
- Publication type:
- Article
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00752-z
- By:
- Publication type:
- Article
Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00655-z
- By:
- Publication type:
- Article
A simple additive staging system for newly diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00611-x
- By:
- Publication type:
- Article
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 11, p. 1, doi. 10.1038/s41408-021-00569-2
- By:
- Publication type:
- Article
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM).
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00548-7
- By:
- Publication type:
- Article
Correction: MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00444-0
- By:
- Publication type:
- Article
Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 12, p. 1, doi. 10.1038/s41408-020-00391-2
- By:
- Publication type:
- Article
Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00353-8
- By:
- Publication type:
- Article
Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00348-5
- By:
- Publication type:
- Article
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 5, p. 1, doi. 10.1038/s41408-020-0319-0
- By:
- Publication type:
- Article
Venetoclax for the treatment of translocation (11;14) AL amyloidosis.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 4, p. 1, doi. 10.1038/s41408-020-0306-5
- By:
- Publication type:
- Article
Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0291-8
- By:
- Publication type:
- Article
Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-019-0266-9
- By:
- Publication type:
- Article
Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.891712
- By:
- Publication type:
- Article
Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel Therapies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. e329, doi. 10.1016/j.clml.2024.05.020
- By:
- Publication type:
- Article
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. e104, doi. 10.1016/j.clml.2023.11.008
- By:
- Publication type:
- Article
P-140: Monoclonal proteinuria ≥200 mg/24h predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S111, doi. 10.1016/S2152-2650(21)02267-9
- By:
- Publication type:
- Article
OAB-037: Assessing the prognostic utility of the Mayo 2018 and IMWG 2020 smoldering multiple myeloma risk stratification scores applied post diagnosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S24, doi. 10.1016/S2152-2650(21)02111-X
- By:
- Publication type:
- Article
MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S435, doi. 10.1016/S2152-2650(21)01970-4
- By:
- Publication type:
- Article
MM-431: A Comparison Between Daratumumab and Non-Daratumumab-Based Salvage Regimens Used at First Relapse Post-Lenalidomide Maintenance in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S444, doi. 10.1016/S2152-2650(21)01987-X
- By:
- Publication type:
- Article
MM-429: Impact of Prolonged Lenalidomide Maintenance (≥3 years) and Outcomes in Patients with Multiple Myeloma Post-Autologous Stem Cell Transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S443, doi. 10.1016/S2152-2650(21)01986-8
- By:
- Publication type:
- Article
IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
- By:
- Publication type:
- Article
Poster: MM-431: A Comparison Between Daratumumab and Non-Daratumumab-Based Salvage Regimens Used at First Relapse Post-Lenalidomide Maintenance in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S256, doi. 10.1016/S2152-2650(21)01611-6
- By:
- Publication type:
- Article
Poster: MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S255, doi. 10.1016/S2152-2650(21)01605-0
- By:
- Publication type:
- Article
Poster: MM-429: Impact of Prolonged Lenalidomide Maintenance (≥3 years) and Outcomes in Patients with Multiple Myeloma Post-Autologous Stem Cell Transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S252, doi. 10.1016/S2152-2650(21)01580-9
- By:
- Publication type:
- Article
Poster: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01536-6
- By:
- Publication type:
- Article
Oral Abstract: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01277-5
- By:
- Publication type:
- Article
The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 7, p. 451, doi. 10.1016/j.clml.2021.02.001
- By:
- Publication type:
- Article
Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The role of bone marrow biopsy in patients with plasma cell disorders; should all patients with a monoclonal protein be biopsied?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e333, doi. 10.1016/j.clml.2019.09.547
- By:
- Publication type:
- Article
Venetoclax For The Treatment of Translocation AL Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e332, doi. 10.1016/j.clml.2019.09.546
- By:
- Publication type:
- Article
Impact of Minimal Residual Negativity on Outcomes in Light Chain Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e331, doi. 10.1016/j.clml.2019.09.545
- By:
- Publication type:
- Article
Blood mass spectrometry Detects Residual Disease Better than Standard Techniques in Immunoglobulin light chain amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e313, doi. 10.1016/j.clml.2019.09.514
- By:
- Publication type:
- Article
Pilot study of Ixazomib, Lenalidomide, and Dexamethasone for Patients with POEMS Syndrome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e311, doi. 10.1016/j.clml.2019.09.512
- By:
- Publication type:
- Article
Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e305, doi. 10.1016/j.clml.2019.09.501
- By:
- Publication type:
- Article
Clinically significant delay in engraftment with day -1 melphalan prior to stem cell infusion in myeloma patients receiving stem cell transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e301, doi. 10.1016/j.clml.2019.09.495
- By:
- Publication type:
- Article
Venetoclax for the Treatment of Multiple Myeloma: Outcomes Outside of Clinical Trials.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e278, doi. 10.1016/j.clml.2019.09.459
- By:
- Publication type:
- Article